BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 209890)

  • 21. [Adenosine cyclic monophosphate level, adenyl cyclase activity, 3,5'-cyclic AMP phosphodiesterase and protein kinases in rat brain in experimental carbon monoxide poisoning].
    Sikorska M
    Neuropatol Pol; 1980; 18(2):203-17. PubMed ID: 6251408
    [No Abstract]   [Full Text] [Related]  

  • 22. [Kinetic properties and regulation of cyclic nucleotide phosphodiesterases in lymphoid cells].
    Azhaeva EV; Severin ES
    Bioorg Khim; 1987 Sep; 13(9):1157-63. PubMed ID: 2827690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and degradation of cyclic nucleotides in brain after a high dose of ionizing radiation.
    Hunt WA; Dalton TK
    Radiat Res; 1981 Mar; 85(3):604-8. PubMed ID: 6111104
    [No Abstract]   [Full Text] [Related]  

  • 24. Alcohol potentiation of isoproterenol-stimulated cyclic AMP accumulation in rat parotid.
    Harper JF; Brooker G
    J Cyclic Nucleotide Res; 1980; 6(1):51-62. PubMed ID: 6247374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclic nucleotide phosphodiesterases.
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():1-416. PubMed ID: 6326516
    [No Abstract]   [Full Text] [Related]  

  • 26. [Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues].
    Medvedeva MV
    Biokhimiia; 1995 Mar; 60(3):364-86. PubMed ID: 7734612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aggregation states of cyclic nucleotide phosphodiesterase of murine thymocytes.
    Sobolev AS; Rybalkin SD
    Cell Biochem Funct; 1986 Jul; 4(3):205-11. PubMed ID: 3015450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin stimulation of cyclic AMP phosphodiesterase is independent from the G-protein pathways involved in adenylate cyclase regulation.
    Weber HW; Chung FZ; Day K; Appleman MM
    J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(5):345-54. PubMed ID: 3040818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective inhibitors of three forms of cyclic nucleotide phosphodiesterase--basic and potential clinical applications.
    Hidaka H; Endo T
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():245-59. PubMed ID: 6144253
    [No Abstract]   [Full Text] [Related]  

  • 30. Regulation of specific forms of cyclic nucleotide phosphodiesterases in cultured cells.
    Manganiello VC; Yamamoto T; Elks M; Lin MC; Vaughan M
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():291-301. PubMed ID: 6326529
    [No Abstract]   [Full Text] [Related]  

  • 31. [Concentration and metabolism of cyclic AMP during the early stages of hepatoma 22a growth].
    Solntseva TI; Belousova AK
    Biull Eksp Biol Med; 1977 Oct; 84(10):472-4. PubMed ID: 199292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heavy metals and adenosine cyclic 3',5'-monophosphate metabolism: possible relevance to heavy metal toxicity.
    Nathanson JA; Bloom FE
    Mol Pharmacol; 1976 May; 12(3):390-8. PubMed ID: 180396
    [No Abstract]   [Full Text] [Related]  

  • 33. Adenylate cyclase, cyclic adenosin 3':5'-monophosphate phosphodiesterase, and regression of Walker 256 mammary carcinoma.
    Cho-Chung YS; Newcomer SF
    Cancer Res; 1977 Dec; 37(12):4493-9. PubMed ID: 200352
    [No Abstract]   [Full Text] [Related]  

  • 34. Alterations in TSH-receptor in two transplantable rat thyroid tumors.
    Macchia V; Meldolesi MF; Mandato E
    Ann Radiol (Paris); 1977; 20(8):752-6. PubMed ID: 205162
    [No Abstract]   [Full Text] [Related]  

  • 35. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics.
    Weishaar RE; Quade MM; Schenden JA; Evans DB
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(6):551-64. PubMed ID: 3003170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclic AMP, adenylate cyclase and cyclic AMP-phosphodiesterase activities in diabetic rat adipocytes.
    Chiappe de Cingolani GE
    Acta Physiol Pharmacol Latinoam; 1986; 36(1):39-46. PubMed ID: 3020875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclic nucleotide phosphodiesterase of normal and leukemic lymphocytes. Kinetic properties and selective alteration of the activity of the multiple molecular forms.
    Hait WN; Weiss B
    Mol Pharmacol; 1979 Nov; 16(3):851-64. PubMed ID: 231197
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of chronic reserpine administration on beta adrenergic receptors, adenylate cyclase and phosphodiesterase of the rat submandibular gland.
    Bylund DB; Forte LR; Morgan DW; Martinez JR
    J Pharmacol Exp Ther; 1981 Jul; 218(1):134-41. PubMed ID: 6113277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subsensitivity of the beta-adrenergic receptor-linked adenylate cyclase system of rat pineal gland following repeated treatment with desmethylimipramine and nialamide.
    Moyer JA; Greenberg LH; Frazer A; Weiss B
    Mol Pharmacol; 1981 Mar; 19(2):187-93. PubMed ID: 6262613
    [No Abstract]   [Full Text] [Related]  

  • 40. Altered responsiveness of cerebral beta adrenoceptors assessed by adenosine cyclic 3',5'-monophosphate formation and (3H)propranolol binding.
    Nahorski SR
    Mol Pharmacol; 1977 Jul; 13(4):679-89. PubMed ID: 196175
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.